US Broker Ratings

Bristol-Myers Squibb (BMY) Stock Analysis: A Solid Dividend Payout Amidst Modest Growth Potential

Bristol-Myers Squibb Company (NYSE: BMY), a titan in the healthcare sector, continues to be a cornerstone for many portfolios with its robust dividend yield and promising drug pipeline. With a..

Labcorp Holdings Inc. (LH) Stock Analysis: Exploring a 10.51% Potential Upside

Labcorp Holdings Inc. (NYSE: LH), a leader in the healthcare sector’s diagnostics and research industry, presents a compelling case for investors as it continues to drive growth and offer potential..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: A Promising 15% Upside as Analysts Rally Behind Biotech Giant

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is a leading force in the biotechnology sector, renowned for its innovative approach to developing and commercializing medicines addressing a wide array of diseases. Headquartered..

McKesson Corporation (MCK) Stock Analysis: A Healthcare Giant with a 13.73% Upside Potential

McKesson Corporation (NYSE: MCK), a titan in the healthcare sector, continues to show promising growth prospects, captivating investors with its strong market presence and potential upside of 13.73%, according to..

Alnylam Pharmaceuticals (ALNY): Investor Outlook with a 41% Potential Upside in the Biotech Sector

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leader in the biotechnology sector, has been making waves with its revolutionary approach to therapeutics based on ribonucleic acid interference (RNAi). As of the..

Haleon plc (HLN) Investor Outlook: Exploring a Potential 12.92% Upside in the Healthcare Sector

Haleon plc (HLN), a stalwart in the healthcare sector, presents a unique proposition for investors seeking exposure to the burgeoning field of consumer healthcare products. With a robust market capitalization..

CVS Health Corporation (CVS) Stock Analysis: Evaluating a 27% Upside Amidst Strong Buy Ratings

Investors eyeing the healthcare sector should take note of CVS Health Corporation (NYSE: CVS), a prominent player in the healthcare plans industry. With a substantial market capitalization of $94.6 billion,..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Exploring a 21.34% Upside Potential in the Healthcare Sector

Intuitive Surgical, Inc. (NASDAQ: ISRG) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a formidable market capitalization of $180.75 billion,..

Medtronic plc (MDT) Stock Analysis: A Healthcare Titan with a 7.65% Upside Potential

Medtronic plc (NYSE: MDT), a stalwart in the healthcare sector, stands as a beacon for investors seeking stability and growth within the medical devices industry. Headquartered in Ireland, Medtronic boasts..

Zoetis Inc. (ZTS) Stock Report: 23.75% Potential Upside and Strong Buy Ratings in Animal Health Sector

Zoetis Inc. (ZTS), a leading player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, commands significant attention from investors keen on tapping into the robust..

Johnson & Johnson (JNJ) Stock Analysis: A Healthcare Giant with a Strong Return on Equity and Steady Dividend Yield

Johnson & Johnson (NYSE: JNJ), a titan in the healthcare sector, continues to be a mainstay for investors seeking stability and growth in the volatile drug manufacturing industry. With a..

Cencora, Inc. (COR) Stock Analysis: Healthcare Giant Shows 11% Upside Potential and Robust Earnings

Cencora, Inc. (NYSE: COR), a titanic entity in the healthcare sector, is making waves in the medical distribution industry. With a market capitalization of $69.88 billion, this U.S.-based company has..

The Cigna Group (CI) Stock Analysis: Unveiling a 19.27% Potential Upside for Investors

The Cigna Group (NYSE: CI), a stalwart in the healthcare plans industry, offers a range of insurance and related services primarily in the United States. With a current market capitalization..

Eli Lilly (LLY) Stock Analysis: Impressive Revenue Growth and Strategic Collaborations Highlight Growth Potential

Eli Lilly and Company (NYSE: LLY), a titan in the healthcare sector, continues to captivate investor interest with its robust financial performance and strategic partnerships. With a market capitalization nearing..

AbbVie Inc. (ABBV) Stock Analysis: Navigating a 9.12% Potential Upside in the Healthcare Sector

AbbVie Inc. (NYSE: ABBV), a stalwart in the healthcare sector, is capturing investor attention with its substantial market cap of $394.14 billion and a promising potential upside of 9.12%. As..

Novo Nordisk A/S (NVO) Stock Analysis: A Healthcare Giant with a Strong Return on Equity and Growth Potential

Novo Nordisk A/S (NVO) stands as a formidable player in the healthcare sector, specializing in drug manufacturing. Headquartered in Bagsvaerd, Denmark, the company is renowned for its focus on diabetes,..

Abbott Laboratories (ABT) Stock Analysis: Healthcare Giant Offers 22.82% Potential Upside

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, continues to capture investor interest with a substantial market capitalization of $190.23 billion. Specializing in medical devices, Abbott has a..

Autolus Therapeutics (AUTL) Stock Analysis: A Biotech Gem with a 550% Upside Potential

For investors with a penchant for high-risk, high-reward scenarios, Autolus Therapeutics plc (NASDAQ: AUTL) presents a compelling case. A clinical-stage biopharmaceutical company based in the United Kingdom, Autolus is pioneering..

AtaiBeckley Inc. (ATAI) Stock Analysis: A 219.60% Upside Potential in Innovative Mental Health Treatments

AtaiBeckley Inc. (NASDAQ: ATAI) is garnering significant attention in the biotechnology sector, particularly due to its focus on pioneering treatments for mental health disorders. With an impressive 219.60% potential upside..

Standard BioTools Inc. (LAB) Stock Analysis: Navigating Challenges with a 9.93% Potential Upside

Standard BioTools Inc. (NASDAQ: LAB), a key player in the healthcare sector focusing on medical devices, is navigating a challenging landscape with its innovative proteomics and genomics solutions. The company,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds